Reproductive Medicine Group
Early Reproductive Events
- Carmen J. Williams, M.D., Ph.D.
- Tel 919-541-2158
- P.O. Box 12233Mail Drop E4-05Durham, N.C. 27709
Carmen Williams, M.D., Ph.D., leads the Reproductive Medicine Group, and holds a secondary appointment in the NIEHS Epigenetics & Stem Cell Biology Laboratory. Her group addresses the mission of the NIEHS by carrying out basic research to promote our understanding of the effects of the environment on human reproductive health, particularly during sensitive developmental windows. Research in the group focuses on basic reproductive biology of early mammalian embryogenesis including gametes, fertilization, preimplantation embryo development, and implantation. This basic bench science addresses specific questions that have direct relevance to human reproduction, including how the environment influences reproductive success.
Mechanisms underlying effects of environmental chemical exposures on early reproduction
Naturally occurring phytoestrogens (estrogenic chemicals found in plants) are readily available in the diet, and many estrogenic chemicals are released into the environment. Depending on the dose and timing of exposure, these types of chemicals can have both beneficial and detrimental effects on health. We use a mouse model to study the effects on female reproductive health of neonatal exposure to estrogenic chemicals. Female mice exposed immediately after birth to estrogenic chemicals have multi-oocyte follicles, lack regular estrus cycles, and are completely infertile even after superovulation because of defects in how the oviduct and uterus function. We are currently examining the epigenetic molecular mechanisms underlying how estrogenic chemical exposure leads to these defects in the reproductive tract environment. This project has direct relevance to understanding how endocrine disrupting chemicals or other environmental factors can impact early reproductive events and potentially lead to reproductive failure in women.
Signal transduction mechanisms of egg activation and preimplantation embryo development
The transition of an unfertilized egg, which is arrested in metaphase of meiosis II, to a developing totipotent embryo, requires completion of a sequence of events known as egg activation. These events include cortical granule exocytosis, modifications of the zona pellucida and plasma membrane that prevent polyspermy, completion of meiosis, recruitment of maternal mRNAs into polysomes for translation, formation of male and female pronuclei, and activation of the embryonic genome. Egg activation is initiated by repetitive oscillations in intracellular calcium. These oscillations begin after sperm-egg plasma membrane fusion when the sperm releases phospholipase C zeta (PLCζ) into the egg’s cytoplasm. Continuation of these oscillations requires calcium entry into the egg from the extracellular medium to replenish calcium stores. In addition, this calcium influx triggers signaling pathways important for polar body emission. We hypothesize that inadequate calcium oscillatory patterns at fertilization, which are supported by calcium influx, could explain a spectrum of failure for the infertile couple, including failed fertilization, poor preimplantation embryo development, and even clinical pregnancy followed by miscarriage.
Major areas of research:
- Effects of the environment on gamete and embryo quality and reproductive tract function
- Signal transduction mechanisms of egg activation and preimplantation embryo development
- Epigenetic mechanisms underlying effects of neonatal estrogenic chemical exposure on reproductive tract function
- Modulators of embryonic genome activation after fertilization
- Modulators of calcium signaling at fertilization
- Channels that support calcium influx in eggs and early embryos
Williams received an M.D. from Duke University School of Medicine in 1986, then completed a Residency in Obstetrics & Gynecology at Pennsylvania Hospital in 1990 and a Fellowship in Reproductive Endocrinology & Infertility at the University of Pennsylvania in 1993. After her clinical training, she went on to complete a Ph.D. in Cell and Molecular Biology at the University of Pennsylvania in 1997 and subsequent postdoctoral fellowship training at Penn. She became an Assistant Professor of Obstetrics & Gynecology at the University of Pennsylvania in 2000, where she served as an attending physician in the Division of Reproductive Endocrinology & Infertility while running an active basic research laboratory in the Center for Research on Reproduction & Women’s Health. She moved to the NIEHS in September, 2007.